In this Report, the terms "Hooper Holmes," "Company," "we," "us" and "our" refer to Hooper Holmes, Inc. and its subsidiaries.

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q (this "Report") contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including, but not limited to, statements about our plans, strategies and prospects. When used in this Report, the words "expects," "anticipates," "believes," "estimates," "plans," "intends," "could," "will," "may" and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include statements as to our operating results, revenues, sources of revenues, cost of revenues, gross margins, operating and net profits/losses, our new IT systems, for our new Portamedic delivery model and changes in certain service line offerings.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expected. These risks and uncertainties include, but are not limited to, risks related to customer concerns about our financial health, our liquidity, declines in our business, our competition, and our ability to successfully implement the restructure of our Portamedic operations and other cost reduction initiatives. The section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 entitled "Risk Factors" and similar discussions in our other filings with the Securities and Exchange Commission ("SEC") discuss these and other important risks that may affect our business, results of operations, cash flows and financial condition. Investors should consider these factors before deciding to make or maintain an investment in our securities. The forward-looking statements included in this Report are based on information available to us as of the date of this Report. We expressly disclaim any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

Overview

Our Company was founded in 1899. We are a publicly-traded New York corporation whose shares of common stock are listed on the NYSE Amex Stock Exchange. Our corporate headquarters are located in Basking Ridge, New Jersey. Over the last 40 years, our business focus has been on providing health risk assessment services. We are currently engaged in the following service lines:

• Portamedic - performs paramedical and medical examinations of individuals, primarily on behalf of insurance companies in connection with the offering or rating of insurance coverage (mainly life insurance), along with medical examinations of health plan participants in order to provide medical information on plan members to the plan sponsors;

• Heritage Labs - performs tests of blood, urine and oral fluid specimens, primarily generated in connection with the paramedical exams and wellness screenings performed by our Portamedic and Health & Wellness service lines, respectively, and assembles and sells specimen collection kits;

• Health & Wellness - performs risk assessment and risk management services, including biometric screenings, health risk assessments and onsite wellness coaching for health and care management companies, including wellness companies, disease management organizations, clinical research organizations, health plans and others; and

• Hooper Holmes Services - provides telephone interviews of insurance candidates, retrieval of medical records and inspections, risk management solutions and underwriting services for simplified issue products and products requiring full underwriting.

Our Portamedic paramedical examination services accounted for 68.8% and 70.6% of revenues for the three month periods ended June 30, 2012 and 2011, respectively, and 68.8% and 70.6% of revenues for the six month periods ended June 30, 2012 and 2011, respectively. As a provider of health risk assessment services to the insurance industry, our business is subject to seasonality, with third quarter sales typically dropping below the other quarters due to the decline in activity typically experienced by the insurance industry during the summer months.

Restructure of Portamedic Operations

In June 2012, we announced our new model for delivering paramedical exams in our Portamedic service line. Our Portamedic service line has been reorganized into 14 regions, with a leader and customer service team assigned to each. In addition, a new team of 14 Health Professional Managers has been formed to recruit, educate and mentor our national examiner network, and to enhance examiners' professional development.

Over 100 local administrative offices have been replaced by 60 integrated customer service centers strategically located across the 14 regions. Administrative functions such as imaging and billing have been centralized. In addition, every job in our Portamedic service line from senior management to customer service representative has a new position description tied to quality measures that we believe directly align with customer expectations.

These changes comprise a large-scale operational transformation designed to give Hooper Holmes the competitive advantages of faster and more accurate service delivery and lower operating costs. The strategy was enabled by capital investments of approximately $5 million in 2011 to develop five new technology systems. These new systems, now deployed, include a new workflow system for Portamedic operations, known as PartnerLink; ePortamedic.com, a new ordering and status website for insurance agents that diagnoses service requirements based on insurance company rules; a new Life Application Processing Platform that makes it easier for financial advisors and brokers to sell more life insurance; the latest version of our iParamed e-Exam, which allows electronic exams to be completed even in areas with poor wireless connections; and a new direct-to-examiner inventory and tracking system for laboratory testing kits.

We believe that this restructuring and capital investment will address the concerns of our customers related to the paramed industry, which include inconsistent service, delays and scheduling issues.

Highlights for the Three and Six Month Periods Ended June 30, 2012

The Company

Financial Results for the Three Month Period Ended June 30, 2012

For the three month period ended June 30, 2012, consolidated revenues totaled $35.4 million, a 6.7% decline from the corresponding prior year period. Our gross profit totaled $7.1 million for the three month period ended June 30, 2012 versus $9.1 million in the comparable period of the prior year. Our gross profit percentage was 20.0% for the three month period ended June 30, 2012, representing a significant decline from the gross profit percentage of 23.9% for the three month period ended June 30, 2011, primarily attributable to gross profit declines in our Portamedic service line.

SG&A expenses were $11.0 million in the three month period ended June 30, 2012, an increase of $0.5 million, or 4.5%, in comparison to the three month period ended June 30, 2011. During the three month period ended June 30, 2012, restructuring charges totaled $1.6 million, primarily consisting of severance and branch office closure costs related to our Portamedic service line as discussed above. Results for the three month period ended June 30, 2011 included restructuring charges totaling $0.04 million, consisting primarily of severance costs related to our Portamedic service line.

Our operating loss from continuing operations for the three month period ended June 30, 2012 was $5.5 million compared to a $1.5 million loss for the comparable prior year period.

For the three month period ended June 30, 2012, we incurred a net loss from continuing operations of $5.6 million, or $0.08 per share on both a basic and diluted basis, compared to net loss of $1.6 million, or $0.02 per share on both a basic and diluted basis, for the comparable prior year period.

Financial Results for the Six Month Period Ended June 30, 2012

For the six month period ended June 30, 2012, consolidated revenues totaled $74.2 million, a 5.5% decline from the corresponding prior year period. Our gross profit totaled $16.1 million for the six month period ended June 30, 2012 versus $20.0 million in the comparable period of the prior year. Our gross profit percentage was 21.7% for the six month period ended June 30, 2012, representing a significant decline from the gross profit percentage of 25.5% for the six month period ended June 30, 2011.

SG&A expenses were $22.5 million in the six month period ended June 30, 2012, an increase of $1.1 million, or 4.9%, in comparison to the six month period ended June 30, 2011. During the six month period ended June 30, 2012, restructuring charges totaled $2.2 million, primarily consisting of severance and branch closure costs related to our Portamedic service line as discussed above. Results for the six month period ended June 30, 2011 included restructuring charges totaling $0.1 million, primarily consisting of severance and branch office closure costs related to our Portamedic and Heritage Labs service lines.

Our operating loss from continuing operations for the six month period ended June 30, 2012 was $8.6 million compared to a $1.5 million loss for the comparable prior year period.

For the six month period ended June 30, 2012, we incurred a net loss from continuing operations of $8.7 million, or $0.13 per share on both a basic and diluted basis, compared to a net loss of $1.7 million, or $0.02 per share on both a basic and diluted basis, for the comparable prior year period.

For the remainder of 2012, we expect to continue improving our processes and organization structure and focusing on customer channels including brokers, direct marketers, insurance agents and health care companies. We made significant capital investments and operating improvements that have transformed the way we deliver services, improving our competitive position and lowering our cost structure, which should enable profitable growth by the end of this year.

Portamedic

In the quarter ended June 30, 2012, Portamedic revenues decreased approximately 9.1% in comparison to the prior year period. Our revenue decline is primarily attributable to a decline in completed examinations in the second quarter 2012 of 8.0% and a 1.9% reduction in the average revenue per paramedical examination, compared to the second quarter of 2011. We continue to believe that achieving acceptable profitability levels will require top-line revenue growth, including the reversal of past revenue declines. Although we have contracts or billing approvals with over 90% of the insurance carriers in the marketplace, the number of paramedical examinations we complete on life insurance applicants continues to decline. The rate of decline in completed examinations was 8.0% in the second quarter of 2012, which is a higher rate of decline than the first quarter of 2012. The second quarter 2012 number of completed examinations was negatively impacted by implementation issues regarding our new IT system for processing Portamedic customer orders, including system and user-training conversion issues, which have been identified and corrected.

The market for Portamedic's services has been negatively affected by both declining numbers of life insurance applications requiring paramed exams and steady price pressure on Portamedic and its competitors. According to LIMRA's U.S. Individual Life Insurance Sales Trends, 1975 - 2010, there were approximately 9.3 million applications for life insurance completed in the United States in 2010, compared to approximately 17 million applications in 1985. We believe that the market continues to offer opportunities to a company that can sell its services effectively and distinguish itself from its competitors.

During the past several fiscal quarters, we have taken the following steps to increase our market share and improve top-line revenue:

• In the second quarter of 2012, we deployed our new Portamedic service delivery model. The introduction of this new program, which generated $1.6 million in restructure charges during the second quarter of 2012, is expected to enhance our ability to provide faster and more accurate service delivery at lower operating costs.

• In June 2012, we created the position of Vice-President of Portamedic Provider Relations. This position will be dedicated to building our network of health professionals for not only our Portamedic service line, but also our Health and Wellness service line.

• In the second quarter of 2012, we established a team of 14 Health Professional Managers whose functions will be to recruit, educate and mentor our national health professional network.

• In March 2012, we entered into an agreement with a national insurance brokerage firm to provide efficient data acquisition and processing solutions. Using the full breadth of our service capabilities, we expect to improve this brokerage's insurance e-application process.

• We promoted and hired new field sales managers during the second quarter of 2012. We introduced new field sales and regional operations incentive compensation plans and performance measurement systems, while implementing a new Customer Relationship Management system for our sales teams.

• We completed development of a new Portamedic web portal to make it easier for customers to order our services.

• In the first half of 2012, we continued to make capital investments which will enable us to improve our current Portamedic service delivery model and provide greater operational performance and service quality, while reducing operating costs in our current branch office structure.

• We implemented a new warehouse management and inventory control system to reduce costs and improve efficiencies in distributing lab kits to our health professionals.

• We expanded our iParamed e-Exam platform, deploying over 1,000 iParamed-equipped netbooks to health professionals in all 50 states and the District of Columbia.

• In the second quarter of 2012, we completed the rollout of our new IT system for processing Portamedic customer orders (known as "Partnerlink"), which is expected to improve customer service, while lowering future operating costs. As of June 30, 2012, the total cost of the system, including implementation and training costs, totaled approximately $5.1 million of which $1.2 million was incurred in the six month period ended June 30, 2012. During the remainder of 2012, we expect to spend an additional $0.5 million primarily for system enhancements, and additional training and implementation costs.

• In 2011, we successfully completed our annual SOC II engagement (formerly SAS 70 Type II), a third-party review of our IT processes and procedures for handling customer data. We believe this review gives customers confidence in our information controls, information security and technology management processes.

We believe that the steps we are taking to improve our selling ability, and the quality and speed of our services, will enable us to reduce the rate of decline experienced in the last several years.

Heritage Labs

Heritage Labs services consist principally of performing tests of blood, urine and oral fluid specimens and the assembly and sale of kits used in the collection and transportation of such specimens to its lab facility. Heritage Labs revenues in the second quarter of 2012 was $3.3 million, a decrease of 7.1% as compared to the prior year period primarily due to decreased revenue from two of our larger lab kit assembly customers. In the second quarter of 2012, approximately 60% of Heritage Labs revenue came from lab testing and 40% came from the sale of specimen kits.

Most of Heritage Labs revenue originates from paramedical exam companies (including Portamedic), and therefore Heritage Labs is affected by the same negative market trends affecting Portamedic, namely the decline in the number of life insurance applications requiring paramed exams. In response, Heritage Labs has taken the following steps to attempt to expand its market share and increase revenues:

• We have developed a "risk score" methodology to help our insurance clients better understand the mortality implications between and among interactions of multiple tests related to specific disease states. We believe that the mortality data we are providing are unique and more complex than the data being provided by our competitors. We have shared our risk score data set and design approach with major re-insurers to validate our methodology to risk scoring. Our objective has been to assist our clients in their ability to develop new insurance products and establish more accurate premium rating or pricing techniques using the lab mortality data that we have developed.

• We have developed sales initiatives designed to increase the number of paramedical examinations completed by our Portamedic service line that generate lab testing orders for Heritage Labs. We have also developed sales initiatives designed to increase the volume of lab test orders for Heritage Labs that are not generated by Portamedic exams.

While we intend for these measures to increase our market share and revenues, there can be no assurance we will achieve those results. We believe that, as a result of the initiatives noted above, along with Portamedic revenue improvements, we may achieve future growth at Heritage Labs.

Health & Wellness

Health & Wellness revenues in the second quarter of 2012 were $3.8 million, an increase of $1.3 million, or 50.5%, from the prior year period, primarily attributable to an increased number of health screenings performed. In the second quarter of 2012, Health & Wellness performed approximately 70,000 health screenings, compared to 45,000 health screenings in the prior year period. During the second quarter of 2012, we provided our services to 40 health management companies. We have conducted screening events in every state in the U.S. as well as the District of Columbia and Puerto Rico. To date, we have certified approximately 3,200 of the examiners in our network to be "wellness certified" examiners. Approximately 55% of these certified health professionals also perform services for our Portamedic service line.

Health & Wellness services include event scheduling, provision and fulfillment of all supplies (e.g., examination kits, blood pressure cuffs, stadiometers, scales, centrifuges, lab coats, bandages, etc.) at screening events, event management, biometric screenings (height, weight, body mass index, hip, waist, neck, pulse, blood pressure), blood draws via venipuncture or finger stick, lab testing, participant and aggregate reporting, data processing and data transmission. Heritage Labs does all of the testing on the venipuncture samples we collect at health and wellness screenings.

We believe the market for health and wellness is likely to grow over the next three to five years, and that we are well positioned to increase revenues from our biometric screening and coaching services. Several recent milestones expected to grow revenues include:

• We announced that Hooper Holmes had been chosen to collect biological samples for the largest government study of tobacco use ever conducted in the United States. This five year study, which begins in the second half of 2012, will draw upon our strengths, including our national network of local health professionals and Heritage Labs' kit manufacturing. We were chosen for this work by Westat, a leading research and statistical survey organization.

• In October 2011, we appointed Susheel Jain as our new Senior Vice President of Healthcare. Mr. Jain joined us from WellPoint, one of the largest health benefits companies in the country, where he was responsible for developing new care management services, including integrated wellness and incentive solutions. In the first half of 2012, we also added three new sales positions, along with new operations and account manager positions.

We believe that we are well-positioned to capture a significant share of the health and care management market given our Company's unique set of assets, including Heritage Labs, our proprietary Health & Wellness IT system, and our network of certified health professionals. However, the success of Health & Wellness will depend in part upon the yet-to-be-proven benefits of health and care management initiatives to the employers and others who sponsor them.

Hooper Holmes Services

Hooper Holmes Services revenues for the second quarter 2012 were $4.4 million, a decrease of 19.7% in comparison to the prior year period.

APS retrieval and PIL revenues totaled $1.9 million in the second quarter of 2012, a decrease of 26.0% in comparison with the prior year period. This decrease in revenue is primarily due to a decline in the number of APS/PIL units performed during the second quarter of 2012 compared to the prior year period. Revenues from Consumer Services totaled $1.0 million in the second quarter of 2012, a decline of 17.0% as compared to the prior year period. Second quarter 2012 revenue from our underwriting services decreased 12.8%, as compared to the prior year period.

Key Financial and Other Metrics Monitored by Management

In our periodic reports filed with the SEC, we provide certain financial information and metrics about our service lines and information that our management uses in evaluating our performance and financial condition. Our objective in providing this information is to help our shareholders and investors generally understand our overall performance and assess the profitability of our service lines, and our prospects for future net cash flows.

In the second quarter of 2012, the metrics which we monitored included:

• the number of paramedical examinations performed by Portamedic;

• the average revenue per paramedical examination;

• time service performance by geographic territory, from examination order to completion;

• the number of cases scheduled by our centralized Portamedic exam scheduling center;

• the number of completed life insurance applications as tracked by LIMRA (a life insurance industry research organization);

• the number of health screenings completed by Health & Wellness;

• the number of tele-interviewing/underwriting reports we generate;

• the number of specimens tested by Heritage Labs;

• the average revenue per specimen tested;

• budget to actual performance at the branch level as well as in the aggregate; and

• customer and product line margins.

Certain of the above-cited metrics are discussed in the comparative discussion and analysis of our results of operations that follows.

Results of Operations

Comparative Discussion and Analysis of Results of Operations for the three and
six month periods ended June 30, 2012 and 2011

The table below sets forth our revenue by service line for the periods
indicated.

                               For the Three Months Ended June 30,               For the Six Months Ended June 30,
   (in thousands)             2012               2011         % Change          2012             2011         % Change

  Portamedic             $     24,348       $     26,772         (9.1 )%   $    51,014       $    55,390         (7.9 )%
  Heritage Labs                 3,285              3,536         (7.1 )%         6,990             7,167         (2.5 )%
  Health & Wellness             3,844              2,554         50.5  %         7,911             5,970         32.5  %
  Hooper Holmes
  Services                      4,430              5,516        (19.7 )%         9,390            10,987        (14.5 )%
    Subtotal                   35,907             38,378                        75,305            79,514
  Intercompany
  eliminations(a)                (506 )             (450 )                      (1,112 )          (1,009 )
    Total                $     35,401       $     37,928         (6.7 )%   $    74,193       $    78,505         (5.5 )%

(a) represents intercompany sales from Heritage Labs to Portamedic

Revenues

Consolidated revenues for the three month period ended June 30, 2012 were $35.4 million, a decline of $2.5 million, or 6.7%, from the prior year period. For the six month period ended June 30, 2012, our consolidated revenues were $74.2 million compared to $78.5 million in the corresponding period of the prior year.

Portamedic

Portamedic revenues in the second quarter of 2012 were $24.3 million, a decrease of $2.4 million, or 9.1%, compared to the prior year period. For the six month period ended June 30, 2012, revenue decreased to $51.0 million compared to $55.4 million for the same period of the prior year, or 7.9%. The decline in Portamedic revenues reflects the net impact of:

• a decrease in paramedical examinations performed in the second quarter of 2012 of approximately 8.0% (287,000 in the second quarter of 2012, or 4,481 per day, vs. 312,000 in the second quarter of 2011, or 4,873 per day), and in the six month period ended June 30, 2012 of approximately 6.4% (604,000 in the six month period ended June 30, 2012, or 4,719 per day, vs. 645,000 in the six month period ended June 30, 2011, or 5,038 per day); and

• a decrease in average revenue per paramedical examination in the second quarter of 2012 of approximately 1.9% as compared to the second quarter of 2011 ($84.60 in the second quarter of 2012 vs. $86.27 in the second quarter of 2011), and in the six month period ended June 30, 2012, a decrease in average revenue per paramedical examination of approximately 2.2% ($84.07 in the six month period ended June 30, 2012 vs. $85.92 in the six month period ended June 30, 2011).

The reduction in Portamedic revenue in the second quarter 2012 and six months ended June 30, 2012 was due to, among other things, implementation issues regarding our new IT system for processing Portamedic customer orders, including system and user-training conversion issues, as well as a continued weak economy and a reduction in life insurance applications requiring a paramedical exam, and steady pricing pressure in our Portamedic service line. The number of Portamedic examinations declined 8.0% in the second quarter of 2012 and 6.4% in the six months ended June 30, 2012 compared to the comparable prior year periods. Examinations declined 6.5% in 2011 compared to 2010.

Heritage Labs

Heritage Labs revenues in the second quarter of 2012 were $3.3 million, a decrease of $0.3 million, or 7.1%, compared to the prior year period. For the six month period ended June 30, 2012, revenue decreased to $7.0 million compared to $7.2 million for the same period of the prior year, or 2.5%. These decreases in revenue are primarily due to a decline in our lab kit assembly services.

During the second quarter of 2012, revenue from lab testing (approximately 60% of total Heritage Labs revenue in the second quarter of 2012) decreased 2.1% in comparison to the prior year period. For the six month period ended June 30, . . .